A novel, multi-receptor agonist targeting both inflammation and brain chemistry
Active molecules (psilocybin and potentiator molecule) are functionally understood separately, however our research has discovered they work unexpectedly and exceptionally well in combination
Originates from observations of >2,500 human use doses of psilocybin-based formulations in Jamaica
Over 500 assays performed at our laboratory on human cells and tissue cultures informing on formulation, toxicity and anti-inflammatory potential
© 2023 All Rights Reserved